GlassScriptPhysician profile
David J Congdon
NPI 1639123243
$820.12
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $118 · 2021: $202 · 2022: $239 · 2023: $43.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $183.30 | 2019-2023 | Puraply |
| Stryker Corporation | $164.30 | 2019-2022 | |
| Intersect Ent, INC. | $152.28 | 2020-2021 | |
| Acclarent, INC | $100.45 | 2019-2022 | |
| Kaleo, INC. | $63.55 | 2021-2022 | |
| Genzyme Corporation | $38.82 | 2020-2022 | |
| Medtronic, INC. | $21.58 | 2022 | |
| Aerin Medical INC. | $21.03 | 2019 | |
| Optinose US, INC. | $20.60 | 2020 | |
| Integra Lifesciences Corporation | $18.32 | 2022 | |
| Ethicon US, LLC | $12.58 | 2019 | |
| Dusa Pharmaceuticals, INC. | $12.47 | 2019 | |
| Medline Industries LP | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Congdon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.